Security Risks Found in Illumina's DNA Sequencing Machines

TL;DR
The FDA has warned healthcare providers that Illumina's DNA sequencers have a security vulnerability that could allow unauthorized users to access or alter potentially important medical data. This comes at a time when Illumina is facing a proxy battle by Carl Icahn, who is seeking to add three new members to the board and remove CEO Francis deSouza.
Topics:businesshealthcare-technology#dna-sequencers#fda#healthcare-technology#illumina#medical-data#security-vulnerability
Want the full story? Read the original reporting
Read on STAT